ALSO NOTED: Archimedes buys Link; Generex plans human bird flu trial;and much more...
> The UK's Archimedes Pharma has acquired Link Holdings, a UK-based pharmaceuticals group that focuses on sales and marketing of specialty pharmaceuticals with commercial operations in the UK, France and Germany. Report
> Generex has entered into an agreement with the Lebanese-Canadian Hospital in Beirut, Lebanon to conduct a human clinical trial of the Antigen Express synthetic avian influenza vaccine, representing the first studies to be conducted in man. Release
> The new federal drug benefit has proven to be a big winner for big pharma. Report
> Poniard is touting positive interim survival data from a Phase II trial of picoplatin in patients with small cell lung cancer. Release
> Isogenica has signed a pact with UCB to employ its CIS display technology to identify peptide ligands to an undisclosed target. Report